Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease
Covid19, Respiratory Muscle Training, Respiratory Function Test
About this trial
This is an interventional treatment trial for Covid19 focused on measuring COVID-19, Respiratory Muscle Training, Respiratory Function Test, Quality of Life, Psychosocial Factor
Eligibility Criteria
Inclusion Criteria:
- Positive diagnosis of COVID-19 (SARS-CoV2)
- Hospital admission for COVID-19 in the last 3 months
- Stable phase and home discharge;
Exclusion Criteria:
- Severe cognitive impairment
- Any type of musculoskeletal, neurological, cardiac or respiratory disease where training is contraindicated
- Inability to carry out the training program through telematic supervision.
Sites / Locations
- UComplutenseMadrid
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Sham Comparator
Experimental
Sham Comparator
Inspiratory muscle training group
Inspiratory muscle training placebo group
Inspiratory + expiratory muscle training group
Inspiratory + expiratory muscle training placebo group
Participants will perform an inspiratory muscle training by a threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.
Participants will perform an inspiratory muscle training by a placebo threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.
Participants will perform an inspiratory and expiratory muscle training by a threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.
Participants will perform an inspiratory and expiratory muscle training by a placebo threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.